Lonza Clonetics LGM-3 lymphocyte growth medium

Thursday, 11 November, 2010

Lonza Clonetics LGM-3 lymphocyte growth medium

Clonetics LGM-3 was developed for the growth and support of human lymphocytes and dendritic cells and comes complete with albumin, insulin, transferrin and gentamicin as the antimicrobial agent.

Each lot is tested for sterility, pH7, osmolality 300 mOsm, protein level 1 mg/mL and endotoxin <1 EU/mL. All raw materials are tested for mycoplasma.

LGM-3 has a shelf life of one year from the manufacture date.

Related Products

Antibodies Inc recombinant antibodies

Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.

Bioss Multiplex Fluorescent IHC Staining Kit

The Bioss Multiplex Fluorescent (5 Colors) IHC Staining Kit enables the simultaneous detection of...

AdipoGen immune checkpoint reagents for immuno-oncology research

AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...

Content from other channels on our network

Sale of Hobart Private Hospital to Calvary raises concerns

Opinion: The growing risk of AI-driven self-diagnosis in breast health

A new national approach to clinical governance

Opinion: The debate over the government's aged care algorithm is missing the point

Commonwealth Home Support Program extended to 30 June 2029

APPEX 2027: The Industry Event Powered by APPMA Returns to Melbourne

From bottleneck to backbone: rethinking water in F&B manufacturing

Barry Callebaut appoints new Chief Operating Officer

Arnott's Group celebrates its suppliers at Sydney event

Record growth for food and grocery manufacturing sector, AFGC reports

Engineers Australia supports national engineer registration

Asahi to use recycled material for all plastic soft drink bottles

Queensland Government and CSIRO launch free R&D program for SMEs

Applications open in WA for submarine sustainment contracts

Construction begins on WA gallium project

All content Copyright © 2026 Westwick-Farrow Pty Ltd